Novo Nordisk A/SNVONYSE
Loading
Asset Growth Under PressureDecelerating
Percentile Rank57
3Y CAGR-11.7%
5Y CAGR-8.8%
Year-over-Year Change
Year-over-year total asset growth rate
3Y CAGR
-11.7%/yr
vs +30.8%/yr prior
5Y CAGR
-8.8%/yr
Consistent
Acceleration
-42.5pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 16.55% |
| 2024 | 48.11% |
| 2023 | 30.35% |
| 2022 | 24.03% |
| 2021 | 716.50% |
| 2020 | 26.25% |
| 2019 | -82.97% |
| 2018 | 8.22% |
| 2017 | 4.94% |
| 2016 | 6.25% |